Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk

Breast Cancer Research

Volumn 9, Issue 2, 2007, Pages

  Baynes, Caroline ^a   Healey, Catherine S ^a   Pooley, Karen A ^a   Scollen, Serena ^a   Luben, Robert N ^a   Thompson, Deborah J ^a   Pharoah, Paul D P ^a   Easton, Douglas F ^a   Ponder, Bruce A J ^a   Dunning, Alison M ^a   Abraham, Jean ^b   Ahmed, Shahana ^b   Antoniou, Antonis ^b   Benusiglio, Patrick ^b   Blows, Fiona ^b   Cebrian, Arancha ^b   Conroy, Don ^b   Curzon, Bridget ^b   Dew, Gary ^b   Driver, Kristy ^b   Field, Helen ^b   Harrington, Patricia ^b   Jordan, Clare ^b   Lesueur, Fabienne ^b   Luccarini, Craig ^b   Mayes, Rebecca ^b   Munday, Hannah ^b   Perkins, Barbara ^b   Redman, Karen ^b   Shah, Mitul ^b   Tyrer, Jonathan ^b   Smith, Paula ^b   West, Judy ^b   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 2; PROTEIN P53; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; MIDDLE AGED; RISK; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK; TUMOR SUPPRESSOR PROTEINS;

EID: 34250188802     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1669     Document Type: Article

References (24)

1. CHEK2 Breast Cancer Case-Control Consortium CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies Am J Hum Genet 2004, 74:1175-1182 1182081 15122511 10.1086/421251
2. Anglian Breast Cancer Study Group Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases Br J Cancer 2000, 83:1301-1308 10.1054/bjoc.2000.1407 11044354
3. Peto J Collins N Barfoot R Seal S Warren W Rahman N Easton DF Evans C Deacon J Stratton MR Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Natl Cancer Inst 1999, 91:943-949 10.1093/jnci/91.11.943 10359546
4. Antoniou AC Pharoah PD McMullan G Day NE Stratton MR Peto J Ponder BJ Easton DF A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes Br J Cancer 2002, 86:76-83 10.1038/ sj.bjc.6600008 11857015
5. Pharoah PD Antoniou A Bobrow M Zimmern RL Easton DF Ponder BA Polygenic susceptibility to breast cancer and implications for prevention Nat Genet 2002, 31:33-36 10.1038/ng853 11984562
6. Tamimi Y Lines M Coca-Prados M Walter MA Identification of target genes regulated by FOXC1 using nickel agarose-based chromatin enrichment Invest Ophthalmol Vis Sci 2004, 45:3904-3913 10.1167/iovs.04-0628 15505035
7. Cox DG Kraft P Hankinson SE Hunter DJ Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer Breast Cancer Res 2005, 7:R171-R175 1064127 15743496 10.1186/bcr973
8. Freedman ML Penney KL Stram DO Riley S McKean-Cowdin R Le Marchand L Altshuler D Haiman CA A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk Cancer Res 2005, 65:7516-7522 10.1158/ 0008-5472.CAN-05-0132 16103107
9. Freedman ML Penney KL Stram DO Le Marchand L Hirschhorn JN Kolonel LN Altshuler D Henderson BE Haiman CA Common variation in BRCA2 and breast cancer risk: A haplotype-based analysis in the Multiethnic Cohort Hum Mol Genet 2004, 13:2431-2441 10.1093/hmg/ddh270 15317758
10. Cox DG Hankinson SE Hunter DJ No association between BRCA2 N372H and breast cancer risk Cancer Epidemiol Biomarkers Prev 2005, 14:1353-1354 10.1158/1055-9965.EPI-04-0848 15894703
11. Healey CS Dunning AM Teare MD Chase D Parker L Burn J Chang-Claude J Mannermaa A Kataja V Huntsman DG A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability Nat Genet 2000, 26:362-364 10.1038/81691 11062481
12. Spurdle AB Hopper JL Chen X Dite GS Cui J McCredie MR Giles GG Ellis-Steinborner S Venter DJ Newman B The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years Cancer Epidemiol Biomarkers Prev 2002, 11:413-416 11927503
13. Einarsdottir K Humphreys K Bonnard C Palmgren J Iles MM Sjolander A Li Y Chia KS Liu ET Hall P Linkage disequilibrium mapping of CHEK2: Common variation and breast cancer risk PLoS Med 2006, 3:e168 1457009 16671833 10.1371/journal.pmed.0030168
14. Goode EL Ulrich CM Potter JD Polymorphisms in DNA repair genes and associations with cancer risk Cancer Epidemiol Biomarkers Prev 2002, 11:1513-1530 12496039
15. NIEHS Environmental Genome Project http://egp.gs.washington.edu/
16. HAPMAP Project http://www.HAPMAP.org
17. Stram DO Haiman CA Hirschhorn JN Altshuler D Kolonel LN Henderson BE Pike MC Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study Hum Hered 2003, 55:27-36 10.1159/000071807 12890923
18. Breast Cancer Association Consortium Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium J Natl Cancer Inst 2006, 98:1382-1396 17018785
19. Dunning AM Chiano M Smith NR Dearden J Gore M Oakes S Wilson C Stratton M Peto J Easton D Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population Hum Mol Genet 1997. 6:285-289 10.1093/hmg/6.2.285 9063749
20. Thorstenson YR Shen P Tusher VG Wayne TL Davis RW Chu G Oefner PJ Global analysis of ATM polymorphism reveals significant functional constraint Am J Hum Genet 2001, 69:396-412 1235311 11443540 10.1086/321296
21. Teare MD Cox A Shorto J Anderson C Bishop DT Cannings C Heterozygote excess is repeatedly observed in females at the BRCA2 locus N372H J Med Genet 2004, 41:523-528 10.1136/jmg.2003.017293 15235023
22. BIC Database http://research.nhgri.nih.gov/bic/
23. Renwick A Thompson D Seal S Kelly P Chagtai T Ahmed M North B Jayatilake H Barfoot R Spanova K ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nat Genet 2006, 38:873-875 10.1038/ ng1837 16832357
24. Stredrick DL Garcia-Closas M Pineda MA Bhatti P Alexander BH Doody MM Lissowska J Peplonska B Brinton LA Chanock SJ The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer Hum Mutat 2006, 27:538-544 10.1002/humu.20323 16652348